Wintrust Investments’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$104K Sell
1,049
-618
-37% -$63.7K 0.09% 160
2024
Q3
$189K Sell
1,667
-16,323
-91% -$1.94M 0.14% 140
2024
Q2
$2.23M Buy
17,990
+361
+2% +$46.5K 0.18% 110
2024
Q1
$2.33M Sell
17,629
-512
-3% -$63.1K 0.21% 103
2023
Q4
$1.98M Sell
18,141
-348
-2% -$36.1K 0.19% 109
2023
Q3
$1.9M Buy
18,489
+74
+0.4% +$7.98K 0.2% 105
2023
Q2
$2.13M Buy
+18,415
New +$2.09M 0.21% 97
2022
Q4
Sell
-17,595
Closed -$1.51M 401
2022
Q3
$1.51M Buy
17,595
+9
+0.1% +$803 0.19% 104
2022
Q2
$1.6M Sell
17,586
-708
-4% -$62.8K 0.19% 98
2022
Q1
$1.5M Buy
18,294
+126
+0.7% +$9.93K 0.14% 126
2021
Q4
$1.39M Buy
+18,168
New +$1.45M 0.13% 133
2021
Q3
Sell
-17,454
Closed -$1.36M 362
2021
Q2
$1.36M Sell
17,454
-1,524
-8% -$113K 0.14% 130
2021
Q1
$1.4M Buy
+18,978
New +$1.4M 0.14% 136
2020
Q4
Sell
-19,054
Closed -$1.51M 298
2020
Q3
$1.51M Buy
19,054
+626
+3% +$49K 0.21% 97
2020
Q2
$1.36M Buy
18,428
+417
+2% +$31.4K 0.19% 92
2020
Q1
$1.32M Sell
18,011
-276
-2% -$21.7K 0.22% 81
2019
Q4
$1.59M Sell
18,287
-264
-1% -$21.7K 0.22% 86
2019
Q3
$1.49M Buy
18,551
+451
+2% +$36.1K 0.22% 81
2019
Q2
$1.45M Buy
18,100
+3,967
+28% +$304K 0.22% 89
2019
Q1
$1.12M Buy
14,133
+1,038
+8% +$77.6K 0.18% 106
2018
Q4
$955K Buy
13,095
+875
+7% +$61.8K 0.18% 109
2018
Q3
$827K Buy
12,220
+84
+0.7% +$5.35K 0.13% 145
2018
Q2
$703K Sell
12,136
-558
-4% -$31.5K 0.12% 162
2018
Q1
$660K Sell
12,694
-7,305
-37% -$395K 0.17% 111
2017
Q4
$1.07M Sell
19,999
-1,384
-6% -$76.7K 0.25% 92
2017
Q3
$1.31M Buy
21,383
+1,076
+5% +$65.2K 0.33% 66
2017
Q2
$1.24M Sell
20,307
-147
-0.7% -$8.95K 0.33% 70
2017
Q1
$1.24M Buy
20,454
+8,677
+74% +$526K 0.35% 67
2016
Q4
$662K Sell
11,777
-192
-2% -$11.2K 0.28% 74
2016
Q3
$713K Buy
11,969
+730
+6% +$42.7K 0.33% 55
2016
Q2
$18K Buy
+11,239
New +$598K 0.04% 144

Other funds holding MRK

Wintrust Investments's MRK Position: Q4 2024 in Review

Wintrust Investments reduced its Merck (MRK) stake by 37% in Q4 2024, selling an estimated $63.7K and leaving 1,049 shares worth $104K. The position accounts for 0.09% of the portfolio, ranked #160.

Wintrust Investments first reported a position in MRK in Q2 2016 and has held it in 31 quarters since. The position peaked at $2.33M in Q1 2024. 3,608 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Wintrust Investments held 1,049 shares of Merck worth $104K as of Q4 2024.
  • Wintrust Investments sold 618 Merck shares in Q4 2024, an estimated $63.7K.
  • Merck made up 0.09% of Wintrust Investments's portfolio in Q4 2024, its #160 holding.
  • Wintrust Investments first reported a position in Merck in Q2 2016 and has held it in 31 quarters since.
  • Wintrust Investments's Merck position peaked at $2.33M in Q1 2024.
  • 3,608 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Wintrust Investments's 13F filing for Q4 2024, filed 10 Feb 2025.